NR4A1 and breast cancer: Particularly, for hormone receptor-positive, early breast cancer it needs to be emphasized that not a single biomarker, but the pattern of the four biomarkers and clinicopathological parameters including stage (reflecting tumor size and nodal status) and histopathological grade is informative for clinical decisions.12